Effects of MAPK inhibitors on CCR4-mediated chemotaxis against thymus and activation-regulated chemokine (TARC/CCL17)

J Dermatol Sci. 2004 Dec;36(3):186-8. doi: 10.1016/j.jdermsci.2004.08.013.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chemokine CCL17
  • Chemokines, CC / physiology*
  • Chemotaxis / physiology*
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • MAP Kinase Signaling System / drug effects*
  • Receptors, CCR4
  • Receptors, Chemokine / physiology*

Substances

  • CCL17 protein, human
  • CCR4 protein, human
  • Chemokine CCL17
  • Chemokines, CC
  • Enzyme Inhibitors
  • Receptors, CCR4
  • Receptors, Chemokine